INREBIC®
(inn-REH-bik)
(Fedratinib)

Chemotherapy 

INREBIC®
(inn-REH-bik)
(Fedratinib)

Chemotherapy

What is INREBIC (Fedratinib)?

INREBIC is a prescription medicine used to treat adults with certain types of myelofibrosis (MF).

It is not known if INREBIC is safe and effective in children.

What is the most important information I should know about INREBIC?

INREBIC can cause serious side effects. These serious side effects include:

How should I take INREBIC?

Nucleic Acid Diagnostic kit

Important Safety Information

Ask your healthcare provider if you do not know.

What should I tell my healthcare provider before taking INREBIC?

Before taking INREBIC, tell your healthcare provider about all your medical conditions, including if you:

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Available 24/7
Experiencing
symotoms that
concern you

General information about INREBIC?

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use INREBIC for conditions for which it was not prescribed. Do not give INREBIC to other people, even if they have the same symptoms you have. It may harm them.

What are the ingredients in INREBIC?

Active ingredient: Fedratinib

Inactive ingredient: Silicified microcrystalline cellulose and sodium stearyl fumarate. The capsule shell contains gelatin, red iron oxide, titanium dioxide and white ink.

Have questions about chemotherapy?

Contact for Second Opinion or Free Counselling

Available 24/7
Experiencing
symotoms that
concern you
Have questions
about cancer?
Just ask Alexa. Find voice-activated answers to 800+ questions on 40+ cancer types.